stored with ticarcillin or carbenicillin at concentrations ranging from 100 to 600 ug/ml at -70°C for 56 days. When an aminoglycoside and carbenicillin or ticarcillin are indicated in patients with renal failure, this study supports the use of ticarcillin with either amikacin or netilmicin.
Aminoglycoside antibiotics in combination with carbenicillin or ticarcillin frequently are used for treatment of patients with infections due to gram-negative bacilli (3, 8, 12 ; J. L. Hoecker, L. K. Pickering, D. Groschel, S. Kohl, and J. van Eys, Cancer, in press). The combination of carbenicillin or ticarcillin with an aminoglycoside provides a broad spectrum of activity against gram-negative bacilli and has been shown to be synergistic against Pseudomonas aeruginosa and various Enterobacteriaceae (1, 2, 6, 11, 13, 17) . Conversely, inactivation of aminoglycoside antibiotics has been shown to be caused by either ticarcillin or carbenicillin (7, 10, 15, 16, 18, 21) . McLaughlin and Reeves (16) demonstrated in vitro inactivation of gentamicin by carbenicillin and suggested that some antagonistic effect might occur in vivo by a combination that had been regarded as synergistic. Riff and Jackson (21) studied the half-life of gentamicin in four patients receiving hemodialysis and found that when carbenicillin and gentamicin were administered concomitantly in a dosage ratio of 80:1, the half-life of gentamicin was markedly reduced. Davies and associates (7) evaluated eight patients with renal failure and found that a 25 to 74% reduction in the half-life of gentamicin resulted from the concomitant administration of therapeutic doses of carbenicillin and ticarcillin. Holt et al. (10) showed that carbenicillin and ticarcillin inactivated gentamicin, tobramycin, sisomicin, and amikacin at a concentration of 50:1 and that this inactivation was least in pooled human sera and greatest in phosphate buffer at pH 7.4. This study was conducted to determine the effect of time and concentration upon the inactivation of four aminoglycoside antibiotics when exposed to were dissolved in pooled human sera obtained from three donors to achieve final concentrations of 5 and 10 ug/ml for gentamicin, netilmicin, and tobramycin, and 10 and 20,ug/ml for amikacin. At the same time, these concentrations of each aminoglycoside antibiotic were mixed separately with 100, 200, 300, and 600 pg/ ml concentrations of ticarcillin or carbenicilin in pooled human sera. All samples were adjusted to a pH of 7.4. Immediately after mixing, a portion of each specimen was assayed for specific aminoglycoside activity. Each mixture then was divided and subjected to the following: (i) incubation at 370C, with further portions being assayed for aminoglycoside activity at 1 and 3 days; (ii) storage at -70°C, with portions being thawed and assayed for residual aminoglycoside activity at 1, 3, 7, and 56 days. Results of residual aminoglycoside activity for each sample are expressed as percent activity when compared to activity at zero time. All samples were assayed in duplicate.
Concentrations of gentamicin and tobramycin were determined by radioenzymatic assay, using an adenyltransferase enzyme (4, 22) . Netilmicin and amikacin were determined by radioenzymatic assay, using an acetyltransferase enzyme (5) . Each assay has a standard curve linear from 1 to 100 iLg/ml and a withinand-between assay precision of 6%. Samples containing tobramycin and netilmicin also were assayed for activity by using microbiological and radioimmune assays as previously reported by us (4, 5) . Bacillus globogii and Klebsiella pneumoniae were used as the test organisms for tobramycin and netilmicin, respectively. Results were compared and correlated with the radioenzymatic assay results.
Statistical analysis was performed by using a paired t test within and between groups and linear regression analysis to determine the effect of carbenicillin concentrations ( Fig. 1 ). Values expressed represent mean ± 1 standard error of the mean of three to four separate experiments.
RESULTS
Incubation at 37°C. The percent activity of the various aminoglycoside antibiotics after incubation with carbenicillin at 37°C at concentration ranging from 100 to 600 Ag/ml for periods of 1 to 3 days are shown in Table 1 . The activity of gentamicin, tobramycin, netilmicin, and amikacin showed no significant decrease with time when carbenicillin was not present. When either 5 or 10 ,ig of gentamicin per ml was incubated with 100 ,ug of carbenicillin per ml, a significant inactivation of gentamicin occurred after 24 h (P < 0.02) and 72 h (P < 0.005). As the concentration of carbenicillin increased, the inactivation of gentamicin became more significant, with the greatest inactivation occurring at carbenicillin concentrations of600 pg/ml. Tobramycin and carbenicillin interaction results were similar to those of gentamicin and carbenicillin, with tobramycin inactivation being directly proportional to carbenicillin concentration (P < 
0.001).
A similar inactivation of tobramycin occurred when 5 and 10 pg of tobramycin per ml were incubated with 100 pg of carbenicillin per ml (1:20 and 1:10, respectively) or when 5 and 10 pug of tobramycin per ml were exposed to 300 pg of carbenicillin per ml (1:60 and 1:30, respectively). No change in netilmicin activity occurred when exposed to 100 ug of carbenicillin per ml; however, as the concentration of carbenicillin increased, inactivation occurred, most noticeably after 72 h of incubation. This inactivation was significantly (P < 0.01) less than seen in gentamicin or tobramycin at all carbenicillin concentrations studied. A similar degree of inactivation occurred when 5 and 10 pg of netilmicin per ml were incubated with 300 pg of carbenicillin per ml (1:60 and 1:30, respectively). Decreases in amikacin activity were significantly (P < 0.001) less at all times and concentrations tested than changes that occurred in gentamicin and tobramycin activity. At clinically relevant concentrations, amikacin inactivation was not different than netilmicin inactivation at carbenicillin concentrations of 100 and 200 ,ug/ml; however, at carbenicillin concentrations of 300 and 600 ug/ml, significantly (P < 0.005) less inactivation of amikacin occurred when compared to netilmicin. Figure 1 depicts linear regression analysis of gentamicin, tobramycin, netilmicin, and amikacin activity when exposed to various concentrations of carbenicillin at 370C for 72 h. There was a direct relationship between the concentration of carbenicillin and the inactivation of each aminoglycoside. The higher the concentration of carbenicillin in the reaction mixture, the greater the inactivation of gentamicin, tobramycin, netilmicin, and amikacin (P < 0.001). ANTIMICROB. AGENTS CHEMOTHER. Table 2 shows the percent activity of gentamicin, tobramycin, netilmicin, and amikacin when incubated with ticarcillin at concentrations of 100 to 600 ug/ml for 72 h at 370C. No significant change in aminoglycoside activity occurred when ticarcillin was not present. Ticarcillin concentrations of 200, 300, and 600 ,ug/ml produced significant (P < 0.025) inactivation of gentamicin and tobramycin, with inactivation being directly proportional to the ticarcillin concentration. The activity of netilmicin (5 and 10 ,ug/ml) and amikacin (10 and 20 ug/ml) was constant at ticarcillin concentrations of 100, 200, and 300 ,ug/ml. At a ticarcillin concentration of 600 ,tg/ml, netilnicin and amikacin maintained 83 ± 2.4% and 90 ± 2.6% activity, respectively. These activities were significantly (P < 0.001) greater than remaining activity of gentamicin and tobramycin at the same concentration. Table 3 shows percent aminoglycoside activity after mixing with 300 or 600 ,ug of carbenicillin or ticarcillin per ml and storage at -70°C for 8 weeks. Amikacin and netilmicin underwent no significant change when stored with either carbenicillin or ticarcillin at either concentration. Gentamicin and tobramycin underwent a slight decrease in activity when stored with carbenicillin or ticarcillin at 300 or 600 ,ug/ml concentrations; however, these changes were not significant. No changes were noted when carbenicillin or ticarcillin concentrations of 200 ug or less per ml were used.
PICKERING AND GEARHART
Comparison of the tobramycin radioenzymatic assay with the microbiological assay and the radioimmune assay gave correlation coefficients of 0.97 and 0.95, respectively (n = 24). Comparison of the netilmicin radioenzymatic assay with the microbiological assay and the radioimmune assay yielded correlation coefficients of 0.82 and 0.90, respectively (n = 22) . DISCUSSION Patients with proven or suspected infections due to Pseudomonas aeruginosa often receive carbenicillin or ticarcillin in addition to an aminoglycoside antibiotic (3, 8, 12; Hoecker et al., in press ). The combination of one of these penicillin derivatives with an aminoglycoside has been shown to be synergistic against P. aerugnosa. Conversely, inactivation of aminoglycosides such as gentamicin occurs in the presence of carbenicillin (7, 16) .
In patients with normal renal function, studies have shown no apparent inactivation of gentamicin by carbenicillin (9, 21, 23) , provided the antibiotics were administered separately and not mixed in the same bottle (7, 15, 18) . In most patients, these drugs are excreted at a rate faster Inactivation of each of the aminoglycoside antibiotics in our study was shown to occur by using three different assay procedures. Comparison of the results of these assays showed a significant correlation. One of the methods was a microbiological assay indicating that any inactivation products which were formed were not microbiologically active; however, the potential renal and ototoxicity of these products is unknown. Further work needs to be undertaken to define these products and to determine whether they are capable of producing side effects.
The finding of inactivation of these aminoglycosides in combination with carbenicillin and ticarcillin at 37°C indicates that these specimens should be centrifuged and frozen immediately to ensure accurate determination when perforned.
If the sample to be tested does not contain a penicillin derivative in addition to the aminoglycoside, then transfer or storage of the sterile sample at room temperature will not cause or result in any decrease in aminoglycoside activity (20) . However, if a penicillic derivative such as carbenicillin or ticarcillin is present, then inactivation may occur (4) , and the specimen should be frozen for transport. Some antibiotics such as chloramphenicol undergo no change in activity when incubated and stored at room temperature with numerous other antibiotics, including penicillin derivatives (20a) . 
